Practice guidelines generally recommend delaying lumbar puncture (LP) in patients on dual antiplatelet therapy, with these recommendations often citing an increased risk of hemorrhagic complications, specifically the development of epidural hematomas. However, no data exist about the risks of performing an LP in the setting of dual antiplatelet therapy and conclusions are often based on data from spinal anesthesia literature. We reviewed the medical records of 100 patients who underwent LP while taking dual antiplatelet therapy. We recorded the number of traumatic and bloody cerebrospinal fluid results as well as the presence of any complications occurring within 3 months of the procedure. Complications requiring imaging or hospitalization were considered serious. The most common complication was back pain, which was reported by 2 patients, only 1 of which was ultimately found to be attributable to the procedure. No serious complications occurred. Cerebrospinal fluid analysis was consistent with a traumatic LP, defined as having at least 100 red blood cells per microliter, in 8% of cases. Bloody LP, defined as having 1000 red blood cells per microliter, occurred in 4% of cases. The percentage of traumatic or bloody LPs was within the range reported previously for LPs performed in any setting. Although this is a small study and additional review is necessary, performing LPs in the setting of dual antiplatelet therapy may not pose an increased risk of serious complications.
I
n current clinical practice, lumbar punctures (LPs) are often avoided in patients who are taking aspirin and clopidogrel. 1, 2 This decision is based on the concern about potential complications such as epidural hematomas. Although intuitive, literature underlying this conclusion is considerably limited. A literature review from 1906 to 1994 reported 61 cases of spinal hematomas in the setting of epidural or spinal anesthesia, only 3 of which occurred in the setting of antiplatelet therapy. 3 A prospective study of almost 400 patients receiving preoperative single antiplatelet therapy did not result in any postoperative spinal hematomas. 4 To assess the risks of LP in this setting, we performed a medical record review of outpatient, inpatient, and emergency LPs performed at Mayo Clinic in the past 6 years. On the basis of our own experience, we hypothesized that LPs in this setting might not result in substantial increases in complication rates.
METHODS
We performed a retrospective review of consecutive patients who were evaluated at Mayo Clinic in Rochester, Minnesota, from July 1, 2011, to September 1, 2016. Patients were included if they (1) were older than 18 years, (2) underwent LP in any setting (outpatient, inpatient, and emergency), (3) were on aspirin and clopidogrel at the time of the procedure, (4) had at least 3 months of medical records available for review after their LP, and (5) had at least 1 care provider visit documented after the LP. If the medications were administered while the patient was in the hospital, the medical records were reviewed to ensure that they were not held before the LP. The medical records were additionally reviewed to assess for (1) level of training of the provider performing the procedure, (2) setting in which the LP was performed, (3) coagulation studies and platelet count if obtained within 2 days of the procedure, (4) traumatic and bloody LPs, and (5) signs or symptoms possibly attributable to the LP within 3 months of the procedure. A traumatic LP was defined as having at least 100 red blood cells per microliter, and a bloody LP was defined as having at least 1000 red blood cells per microliter in the cerebrospinal fluid sample. The Wilson Score interval was used to calculate the 95% confidence upper limit for epidural hematomas. The Mayo Clinic Institutional Review Board approved the study.
RESULTS
One hundred patients on dual antiplatelet therapy at the time of the LP were identified. Almost all patients were taking aspirin 81 mg and clopidogrel 75 mg, except for 2 patients who received aspirin 325 mg and clopidogrel 75 mg. The indications for LP varied and are listed in the Table. Most procedures were performed in the outpatient setting (76%) by dedicated LP nurses, whereas 24% were performed emergently or in an inpatient setting. Residents in Neurology, Emergency Medicine, or other specialties performed the LPs in the emergency department and inpatient settings. Various LP needle sizes were used, including 18 gauge (6%), 20 gauge (69%), and 22 gauge (25%). In 86% of cases, only 1 LP attempt was necessary to obtain spinal fluid. Almost all patients with a laboratory evaluation before LP had a platelet count of more than 100,000 and an international normalized ratio of 1.5 or less. The 2 patients with a lower platelet count had clear spinal fluid, whereas 1 patient with an international normalized ratio of 1.5 had bloodstained fluid, which progressively cleared.
Providers performing the LP recorded the presence of gross blood in the cerebrospinal fluid of 6 cases, with 2 of these recording progressive clearance in subsequent vials. In 8% of LPs, cerebrospinal fluid analysis was consistent with a traumatic LP, and 4% met criteria for a bloody LP. No bloody LPs occurred when the 22-gauge needle was used. In our study, the epidural hematoma rate was 0 (95% CI, 0.00-0.04). Two patients reported severe back pain in the first few days after LP, one of which was ultimately found to be a consequence of nephrolithiasis while the other self-resolved over the course of 1 week. One patient had a magnetic resonance imaging of the lumbar spine performed the day after LP; however, this was ordered as part of his initial evaluation, and not after the procedure. There were no abnormal findings on the magnetic resonance imaging. One patient had a computed tomography of the abdomen/pelvis performed because of concern for an intraabdominal infection. In the 3 months after an LP was performed, no hospitalizations or imaging studies were required for any reason potentially attributable to the LP.
DISCUSSION
In this single-center, retrospective review of 100 consecutive patients on dual antiplatelet therapy, LPs did not result in any serious complications. The percentages of traumatic and bloody cerebrospinal fluid results were within the previously published estimated incidence of approximately 10% for bedside studies, and approached the 3.5% incidence published for fluoroscopyguided procedures. 5, 6 Our results are consistent with results of previous studies that evaluated the risk of antiplatelet therapy in the setting of regional anesthesia. In a retrospective review of approximately 300 patients with coronary artery disease or peripheral vascular disease who were taking clopidogrel, epidural anesthesia did not result in any neurologic complications. 7 Of these, most patients were on dual antiplatelet therapy. Given these data, performance of LP in the setting of dual antiplatelet therapy is probably reasonable under conditions in which delaying the procedure may result in moderate to high thrombotic risk or diagnostic uncertainty.
However, caution is prudent, due to the small size of the study and the performance of most LPs in the outpatient setting by experienced LP nurses. Limitations inherent to all retrospective reviews are also present. The cited studies, like ours, were not powered to detect an increased risk of spinal hematoma, which is thought to be rare and has been estimated to occur in 2 per 100,000 cases, during epidural anesthesia administration. 8 Given the significant disability that can result from an epidural hematoma, patients or their surrogates should be carefully counseled before the performance of LP in the setting of dual antiplatelet therapy.
CONCLUSION
While additional studies are necessary, continued review of the safety of antiplatelet use before LPs is reasonable because withholding these agents increases the shortterm risk of thromboembolic complications, causes diagnostic delays, and in some cases impedes ultimate diagnostic certainty, particularly when the LP is requested emergently.
